Serot JM - Search Results

1

Apolipoprotein E polymorphism and serum concentration in Alzheimer's disease in nine European centres: the ApoEurope study. ApoEurope group.

Siest G, Bertrand P, Qin B, Herbeth B, Serot JM, Masana L, Ribalta J, Passmore AP, Evans A, Ferrari M, Franceschi M, Shepherd J, Cuchel M, Beisiegel U, Zuchowsky K, Rukavina AS, Sertic J, Stojanov M, Kostic V, Mitrevski A, Petrova V, Sass C, Merched A, Salonen JT, Tiret L, Visvikis S. Siest G, et al. Among authors: serot jm. Clin Chem Lab Med. 2000 Aug;38(8):721-30. doi: 10.1515/CCLM.2000.102. Clin Chem Lab Med. 2000. PMID: 11071064

2

Myeloperoxidase G-463A polymorphism and Alzheimer's disease in the ApoEurope study.

Leininger-Muller B, Hoy A, Herbeth B, Pfister M, Serot JM, Stavljenic-Rukavina M, Massana L, Passmore P, Siest G, Visvikis S. Leininger-Muller B, et al. Among authors: serot jm. Neurosci Lett. 2003 Oct 2;349(2):95-8. doi: 10.1016/s0304-3940(03)00795-x. Neurosci Lett. 2003. PMID: 12946561

3

Apolipoprotein E, transthyretin and actin in the CSF of Alzheimer's patients: relation with the senile plaques and cytoskeleton biochemistry.

Merched A, Serot JM, Visvikis S, Aguillon D, Faure G, Siest G. Merched A, et al. Among authors: serot jm. FEBS Lett. 1998 Mar 27;425(2):225-8. doi: 10.1016/s0014-5793(98)00234-8. FEBS Lett. 1998. PMID: 9559653 Free article.

4

Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer's disease.

Merched A, Xia Y, Visvikis S, Serot JM, Siest G. Merched A, et al. Among authors: serot jm. Neurobiol Aging. 2000 Jan-Feb;21(1):27-30. doi: 10.1016/s0197-4580(99)00103-7. Neurobiol Aging. 2000. PMID: 10794845 Clinical Trial.

5

Increased protein glycation in cerebrospinal fluid of Alzheimer's disease.

Shuvaev VV, Laffont I, Serot JM, Fujii J, Taniguchi N, Siest G. Shuvaev VV, et al. Among authors: serot jm. Neurobiol Aging. 2001 May-Jun;22(3):397-402. doi: 10.1016/s0197-4580(00)00253-0. Neurobiol Aging. 2001. PMID: 11378244

6

Morphological alterations of the choroid plexus in late-onset Alzheimer's disease.

Serot JM, Béné MC, Foliguet B, Faure GC. Serot JM, et al. Acta Neuropathol. 2000 Feb;99(2):105-8. doi: 10.1007/pl00007412. Acta Neuropathol. 2000. PMID: 10672315

7

CSF-folate levels are decreased in late-onset AD patients.

Serot JM, Christmann D, Dubost T, Béne MC, Faure GC. Serot JM, et al. J Neural Transm (Vienna). 2001;108(1):93-9. doi: 10.1007/s007020170100. J Neural Transm (Vienna). 2001. PMID: 11261750

8

Comparative immunohistochemical characteristics of human choroid plexus in vascular and Alzheimer's dementia.

Serot JM, Bene MC, Faure GC. Serot JM, et al. Hum Pathol. 1994 Nov;25(11):1185-90. doi: 10.1016/0046-8177(94)90035-3. Hum Pathol. 1994. PMID: 7959663

9

Choroid plexus, aging of the brain, and Alzheimer's disease.

Serot JM, Béné MC, Faure GC. Serot JM, et al. Front Biosci. 2003 May 1;8:s515-21. doi: 10.2741/1085. Front Biosci. 2003. PMID: 12700093 Review.

10

Antibodies to choroid plexus in senile dementia of Alzheimer's type.

Serot JM, Béné MC, Gobert B, Christmann D, Leheup B, Faure GC. Serot JM, et al. J Clin Pathol. 1992 Sep;45(9):781-3. doi: 10.1136/jcp.45.9.781. J Clin Pathol. 1992. PMID: 1401207 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters